Cantor Fitzgerald Initiates Coverage On Immuneering with Overweight Rating

Benzinga Newsdesk www.benzinga.com Neutral 69.0%

Neg 0% Neu 69% Pos 0%

Cantor Fitzgerald analyst Li Watsek initiates coverage on Immuneering (NASDAQ:IMRX) with a Overweight rating.

Comments

No comments yet. Be the first!